Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Drug Resistance

  Free Subscription


21.05.2018

1 Am J Trop Med Hyg
6 Antimicrob Agents Chemother
2 Antivir Ther
2 Clin Infect Dis
1 Int J Antimicrob Agents
2 J Antimicrob Chemother
1 J Med Microbiol
1 JAMA
2 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Trop Med Hyg

  1. JAGANATH D, Jorakate P, Makprasert S, Sangwichian O, et al
    Staphylococcus aureus Bacteremia Incidence and Methicillin Resistance in Rural Thailand, 2006-2014.
    Am J Trop Med Hyg. 2018 May 14. doi: 10.4269/ajtmh.17-0631.
    PubMed     Text format     Abstract available


    Antimicrob Agents Chemother

  2. MISIC D, Asanin J, Spergser J, Szostak M, et al
    OXA-72-mediated carbapenem resistance in sequence type 1 multidrug (colistin)-resistant Acinetobacter baumannii associated with urinary tract infection in a dog from Serbia.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00219.
    PubMed     Text format     Abstract available

  3. CHEN K, Dong N, Zhao S, Liu L, et al
    Identification and characterization of conjugative plasmids that encode ciprofloxacin resistance in Salmonella.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00575.
    PubMed     Text format     Abstract available

  4. HUANG HH, Lin YT, Chen PY, Li LH, et al
    ClpA and HtpX Proteases Are Involved in Intrinsic Aminoglycoside Resistance of Stenotrophomonas maltophilia and Are Potential Aminoglycoside Adjuvant Targets.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00554.
    PubMed     Text format     Abstract available

  5. AHMED MN, Porse A, Sommer MOA, Hoiby N, et al
    Evolution of antibiotic resistance in biofilm and planktonic P. aeruginosa populations exposed to sub-inhibitory levels of ciprofloxacin.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00320.
    PubMed     Text format     Abstract available

  6. BABLISHVILI N, Tukvadze N, Shashkina E, Mathema B, et al
    The impact of gyrB and eis mutations in improving second-line drug resistance detection among Mycobacterium tuberculosis isolates from Georgia.
    Antimicrob Agents Chemother. 2017 Jun 19. pii: AAC.01921.
    PubMed     Text format     Abstract available

  7. PATEL N, O'Malley T, Zhang YK, Xia Y, et al
    A novel 6-benzyl ether benzoxaborole is active against Mycobacterium tuberculosis in vitro.
    Antimicrob Agents Chemother. 2017 Jul 3. pii: AAC.01205.
    PubMed     Text format     Abstract available


    Antivir Ther

  8. SIMONETTI FR, Cattaneo D, Zanchetta N, Giacomet V, et al
    Pregnancy-related changes of antiretroviral pharmacokinetics: an argument for TDM.
    Antivir Ther. 2017 Jan 4. doi: 10.3851/IMP3122.
    PubMed     Text format     Abstract available

  9. GILL VC, Lynch T, Ramazani S, Krentz HB, et al
    Reporting on the prevalence of antiretroviral drug resistance in a regional HIV population over 20 years: a word of caution.
    Antivir Ther. 2016 Nov 2. doi: 10.3851/IMP3105.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  10. HEO ST, Tatara AM, Jimenez-Ortigosa C, Jiang Y, et al
    Changes in in vitro susceptibility patterns of Aspergillus to triazoles and correlation with aspergillosis outcome in a tertiary care cancer center (1999-2015).
    Clin Infect Dis. 2017 Mar 31. doi: 10.1093.
    PubMed     Text format     Abstract available

  11. KLEIN EY, Jiang W, Mojica N, Tseng KK, et al
    National Costs Associated with Methicillin-susceptible and Methicillin-resistant S. aureus Hospitalizations in the United States, 2010-2014.
    Clin Infect Dis. 2018 May 12. pii: 4995458. doi: 10.1093.
    PubMed     Text format     Abstract available


    Int J Antimicrob Agents

  12. YAHIA HB, Chairat S, Hamdi N, Gharsa H, et al
    Antimicrobial resistance and genetic lineages of faecal enterococci of wild birds: Emergence of vanA and vanB2 harboring Enterococcus faecalis.
    Int J Antimicrob Agents. 2018 May 14. pii: S0924-8579(18)30136.
    PubMed     Text format     Abstract available


    J Antimicrob Chemother

  13. BACHIR M, Allem R, Benejat L, Tifrit A, et al
    Molecular detection of mutations involved in Helicobacter pylori antibiotic resistance in Algeria.
    J Antimicrob Chemother. 2018 May 11. pii: 4995220. doi: 10.1093.
    PubMed     Text format     Abstract available

  14. NYGAARD JENSEN J, Melander E, Hedin K, Bjerrum L, et al
    Comparison of antibiotic prescribing and antimicrobial resistance in urinary tract infections at the municipal level among women in two Nordic regions.
    J Antimicrob Chemother. 2018 May 10. pii: 4995081. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Med Microbiol

  15. TANG HALLBACK E, Karami N, Adlerberth I, Cardew S, et al
    Methicillin-resistant Staphylococcus argenteus misidentified as methicillin-resistant Staphylococcus aureus emerging in western Sweden.
    J Med Microbiol. 2018 May 17. doi: 10.1099/jmm.0.000760.
    PubMed     Text format     Abstract available


    JAMA

  16. HUTTNER A, Kowalczyk A, Turjeman A, Babich T, et al
    Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial.
    JAMA. 2018;319:1781-1789.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  17. SAITO K, Warrier T, Somersan-Karakaya S, Kaminski L, et al
    Rifamycin action on RNA polymerase in antibiotic-tolerant Mycobacterium tuberculosis results in differentially detectable populations.
    Proc Natl Acad Sci U S A. 2017 May 30. pii: 201705385.
    PubMed     Text format     Abstract available

  18. VILCHEZE C, Hartman T, Weinrick B, Jain P, et al
    Enhanced respiration prevents drug tolerance and drug resistance in Mycobacterium tuberculosis.
    Proc Natl Acad Sci U S A. 2017 Apr 10. pii: 201704376.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: